Weston Nichols's Net Worth

$474 Thousand

Estimate Recalculated Sep 18, 2024 05:40PM EST

Who is Weston Nichols?

Weston Nichols does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., TScan Therapeutics, Inc., and Passage BIO, Inc..

SEC CIK

Weston Nichols's CIK is 0001746376

Past Insider Trading and Trends

2023 was Weston Nichols's most active year for acquiring shares with 2 total transactions. Weston Nichols's most active month to acquire stocks was the month of May. 2023 saw Weston Nichols paying a total of $0.00 for 23,500 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+56.67%
3.4K
—
—
9.4K
Jun 7
Form 4
∞
6K
—
—
6K
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 21
Form 3
—
0
—
—
0
No matching records found

TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 19
Form 4
-0.24%
-25.40K
$2.51
-$63,952.50
10.46M
May 31
Form 3
—
0
—
—
0
No matching records found

Passage BIO, Inc. (PASG) Snapshot price: $0.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found